Associate Director Business Development @ IQVIA | Helping pharma and medtech companies unlock value across the product lifecycle | Project Management Professional (PMP), MSc, BSc
Do you represent a Germany or Austria based Biotechnology Company working on Market Access in Europe? Are you aware of the new EU HTA Regulation coming into force in 2025 for oncology and ATMP (cell & gene) products, and the need to submit a Joint Clinical Assessment (JCA) dossier? If you are not yet up to speed or wondering if you are fully aware of the new requirements and how they will affect your business, please drop me a note. Our Subject Matter experts would be delighted to talk you through the implications, ensuring that you can collect and deliver appropriate evidence for a successful launch. #IQVIA #JCA #DrivingHealthcareForwardTogether #MarketAccess #WeAreIQVIA